Medical Cannabis by Shoppers™ portal to offer Bhang® Chocolate and Wana™ Sour Gummies
LONDON, Ontario, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), a leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce an agreement has been secured with Medical Cannabis by Shoppers Inc., a subsidiary of Shoppers Drug Mart Inc. This agreement will see Bhang® Chocolate and Wana™ Sour Gummies sold through the Medical Cannabis by Shoppers™ business, including Bhang® THC Milk Chocolate, Bhang® THC Dark Chocolate, Bhang® CBD-Dominant Milk Chocolate, Bhang® Caramel Dark Chocolate THC/CBD 1:1, as well as Wana™ Sour Gummies in the following flavours: Watermelon Hybrid, Strawberry Lemonade 1:1, and Mango Sativa.
The Medical Cannabis by Shoppers online platform is a trusted and convenient source of quality medical cannabis, providing patients with single-source access to a broad range of products. Through their national online platform, the Medical Cannabis by Shoppers business connects patients with cannabis products that meet the highest quality and safety standards. The agreement between the Company and Medical Cannabis by Shoppers Inc. will provide Canadian medical cannabis consumers access to Indiva’s market-leading portfolio of cannabis edibles.
“We are thrilled about this agreement with Medical Cannabis by Shoppers Inc., which will see our best-in-class cannabis edibles reach the medical cannabis market,” said Niel Marotta, President and CEO of Indiva. “We are eager to give patients across the country access to different forms of medical cannabis. Both Bhang® and Wana™ have reputations as high-quality products, and we are excited to see them become legitimate options for medical cannabis consumers across Canada.”
Bhang® Chocolate and Wana™ Sour Gummies are expected to be for sale online through the Medical Cannabis by Shoppers site (shoppersdrugmart.ca/cannabis) in the coming days.
ABOUT INDIVA
Indiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva creates premium pre-rolls, flower, capsules, and edible products and provides production and manufacturing services to peer entities. In Canada, Indiva produces and distributes the award-winning Bhang® Chocolate, Wana™ Sour Gummies, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt, Artisan Batch, and other Powered by INDIVA™ products through license agreements and partnerships. Click here to connect with Indiva on LinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.
CONTACTS
MEDIA CONTACT
Meagan Kelly, Marketing and Communications Specialist
Phone: 613-979-6347
Email: mkelly@indiva.com
INVESTOR CONTACT
Anthony Simone
Phone: 416-881-5154
Email: ir@indiva.com
Steve Low
Phone: 647-620-5101
Email: stevelow@indiva.com
DISCLAIMER AND READER ADVISORY
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the contents of this press release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company's future operations, future product offerings and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to maintain the necessary regulatory and other third parties’ approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.